What's Happening?
Blank Rome has announced the addition of Tom Sundlof as a partner in its life sciences industry team and corporate, M&A, and securities practice group in Washington, DC. Sundlof, who previously served in the FDA's Office of the Chief Counsel, will focus on regulatory, compliance, and enforcement matters related to medical devices, combination products, and other FDA-regulated products. His role will involve assisting both domestic and international clients in navigating FDA regulations, from clinical trial design to post-market compliance.
Why It's Important?
The appointment of Tom Sundlof to Blank Rome's life sciences team underscores the firm's commitment to strengthening its regulatory expertise in the healthcare sector. Sundlof's experience with the FDA provides valuable insights into the complex regulatory landscape, which is crucial for clients seeking to bring medical products to market. This move is likely to enhance Blank Rome's ability to advise clients on compliance and enforcement issues, potentially leading to increased business opportunities and client trust. The life sciences industry is a rapidly evolving field, and having seasoned experts like Sundlof can significantly impact the firm's competitive edge.
